Review of cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments
Platinum-based chemotherapy agents initially transformed cancer treatment. However their effectiveness peaked as combined regimes showed little additional benefit in trials. New research frontiers developed with the discovery that conventional chemotherapy can induce immunological cell death by recr...
| Hoofdauteur: | |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
Frontiers Media S.A.
2014-09-01
|
| Reeks: | Oncology Reviews |
| Onderwerpen: | |
| Online toegang: | http://www.oncologyreviews.org/index.php/or/article/view/256 |